CAPTRUST Financial Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-870
| Closed | -$41K | – | 2641 |
|
|
2022
Q2 | $41K | Buy |
870
+18
| +2% | +$848 | ﹤0.01% | 2904 |
|
|
2022
Q1 | $61K | Buy |
852
+660
| +344% | +$47.3K | ﹤0.01% | 2644 |
|
|
2021
Q4 | $14K | Buy |
192
+10
| +5% | +$729 | ﹤0.01% | 3514 |
|
|
2021
Q3 | $10K | Sell |
182
-1
| -0.5% | -$55 | ﹤0.01% | 3598 |
|
|
2021
Q2 | $8K | Sell |
183
-48
| -21% | -$2.1K | ﹤0.01% | 3658 |
|
|
2021
Q1 | $11K | Buy |
231
+191
| +478% | +$9.1K | ﹤0.01% | 3381 |
|
|
2020
Q4 | $2K | Buy |
40
+20
| +100% | +$1K | ﹤0.01% | 3099 |
|
|
2020
Q3 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 2888 |
|